| BCBS Highmark Penn Medicare Advantage | Pertuzumab, trastuzumab, and hyaluronidase-zzxf (Phesgo) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Docetaxel (Taxotere) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Fulvestrant (Faslodex) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Teprotumumab-trbw (Tepezza) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Alemtuzumab (Lemtrada) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Ublituximab-xiiy (Briumvi) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Paclitaxel, albumin-bound (Abraxane ) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Natalizumab (Tysabri) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Paclitaxel (Taxol) | 2025-10-01 |
| BCBS Highmark Penn Medicare Advantage | Allergen Immunotherapy | 2025-10-01 |